Myelodysplasia following treatment of chronic lymphocytic leukemia (CLL) with 2-chlorodeoxyadenosine (2-CdA)
Kroft
S H
SH
Tallman
M S
MS
Shaw
J M
JM
Thangavelu
M
M
Peterson
L C
LC
D000970:Antineoplastic Agents / Q000009:adverse effects*; D002897:Chromosomes, Human, Pair 7; D017338:Cladribine / Q000009:adverse effects*; D017809:Fatal Outcome; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009006:Monosomy; D009190:Myelodysplastic Syndromes / Q000139:chemically induced* / Q000235:genetics
D000970:Antineoplastic Agents; D017338:Cladribine